** This bioprinting survey has now closed **
[UPDATE] As this bioprinting survey has now closed, here are a few top picks from the 3DMedNet Spotlight and our partners while we compile the results:
- Policy briefing: making ‘good targets’ for translational research
- Bioprinting technology, regulation and intellectual property: ‘panel on paper’
- 3D bioprinting in healthcare: opportunities and challenges with Deepak Kalaskar
- Suspended manufacture of a 3D iPSC-derived blood brain barrier with Sam Moxon
If you work in developing bioinks, practising bioprinting techniques or in the design of processes for the eventual translation of bioprinting into clinical medicine, we want to hear from you!
From the first R&D phases to commercializing technologies, we want to see where we are now with bioprinting, what challenges the community is facing in progressing R&D and what the future may hold for the field.
So take a few minutes to complete our bioprinting survey and be the first to receive an infographic with the results!
- How many years’ experience do you have with bioprinting?
- Which disease areas/areas of specialism are you primarily focussed on?
- What are the main limitations of bioprinting today?
- What bioprinting hardware/software/technique are you using?
- How has the number of research projects involving bioprinting technology changed in your institution over the last 5 years?
- How do you think your use of bioprinting across different projects/applications in the next 5 years will change (if at all)?